HLA-C and neoplasm: Tumor cells bind to the NK cell surface receptor KIR2DL via HLA-C molecules, and activate phosphorylation of tyrosine residues in the cytoplasmic ITIM sequence, leading to the recruitment of protein tyrosine phosphatases (PTPs) SHP-1 and SHP-2.